About
As the Chief Scientific Officer of InterVivo, Guy brings over 20 years International CNS Research and Development experience with major BioPharma organizations such as Glaxo-Wellcome, Hoffmann-La Roche, Schering Plough and NPS Pharmaceuticals. As a leader of functional CNS groups in most of these organizations, Guy has demonstrated a sustained commitment to the development and implementation of translational animal models to support the identification and progression of novel chemical entities from early discovery through to clinical development. It is this experience and background that has allowed Guy, together with Joseph, to forge the vision of IVS and its service offerings. Guy has co-authored over 120 research papers and review articles covering aspects of CNS pharmacology, drug discovery and behavioural neuroscience. Guy received his PhD in 1990 and currently holds the position of Adjunct Professor in the Pharmacology department at the University of Toronto.
Investment Focus
- Location
- US
Contact Information
Find more investors like Guy
Search Investors